Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China

Journal of Microbiology

Volumn 48, Issue 5, 2010, Pages 689-694

  Zhang, Jing Ping ^a   Zhu, Wan ^a   Tian, Su Fei ^a   Chu, Yun Zhuo ^a   Chen, Bai Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

lactamase; A. baumannii; efflux system; integron; MLST; PFGE

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; IMIPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; CHINA; CLASSIFICATION; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN; INTEGRON; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHINA; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; IMIPENEM; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING;

ACINETOBACTER BAUMANNII;

EID: 79951528172     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: 10.1007/s12275-010-0137-3     Document Type: Article

References (33)

1. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, OXA-27, molecular class D betalactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanni. Antimicrob. Agents Chemother. 45, 583-588.
2. Bertini, A., A. Giordano, P. Varesi, L. Villa, C. Mancini, and A. Carattoli. 2006. First report of the plasmid-mediated carbapenemhydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob. Agents Chemother. 50, 2268-2269.
3. Brown, S. and S. Amyes. 2006. OXA-lactamases in Acinetobacter: the story so far. J. Antimicrob. Chemother. 57, 1-3.
4. Clinical and Laboratory Standards Institute. 2006. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa, USA.
5. Cetin, E. S., R. Durmaz, T. Tetik, B. Otlu, S. Kaya, and A. Cali kan. 2009. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsedfield gel electrophoresis. Am. J. Infect Control. 37, 56-64.
6. Coelho, J., N. Woodford, M. Afzal-Shah, and D. Livermore. 2006. Occurrence of OXA-58-like carbapene-mases in Acinetobacter spp. Collected over 10 years in three continents. Antimicrob. Agents Chemother. 50, 756-758.
7. Dalla-Costa, L. M., J. M. Coelho, H. A. Souza, M. E. Castro, C. J. Stier, K. L. Bragagnolo, A. Rea-Neto, S. R. Penteado-Filho, D. M. Livermore, and N. Woodford. 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41, 3403-3406.
8. Dijkshoorn, L., H. Aucken, P. Gerner-Smidt, P. Janssen, M. E. Kaufmann, J. Garaizar, J. Ursing, and T. L. Pitt. 1996. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J. Clin. Microbiol. 34, 1519-1525.
9. Gerner-Smidt, P. 1992. Ribotyping of the Acinetobacter calcoaceticus Acinetobacter baumannii complex. J. Clin. Microbiol. 30, 2680-2685.
10. Gouby, A., M. J. Carles-Nurit, N. Bouziges, G. Bourg, R. Mesnard, and P. J. Bouvet. 1992. Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii. J. Clin. Microbiol. 30, 1588-1591.
11. Grundmann, H., S. Hori, M. C. Enright, C. Webster, A. Tami, E. J. Feil, and T. Pitt. 2002. Determining the genetic structure of the natural population of Staphylococcus aureus: a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typing. J. Clin. Microbiol. 40, 4544-4546.
12. Grundmann, H. J., K. J. Towner, L. Dijkshoorn, P. Gerner-Smidt, M. Maher, H. Seifert, and M. Vaneechoutte. 1997. Multi-center study using standardized protocols and reagents for evaluation of reproducibility of PCR based fingerprinting of Acinetobacter spp. J. Clin. Microbiol. 35, 3071-3077.
13. Héritier, C., A. Dubouix, L. Poirel, N. Marty, and P. Nordmann. 2005. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J. Antimicrob. Chemother. 55, 115-118.
14. Homan, W. L., D. Tribe, S. Poznanski, M. Li, G. Hogg, E. Spalburg, J. D. van Embden, and R. J. Willems. 2002. Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol. 40, 1963-1971.
15. Jeon, B., S. H. Jeong, I. K. Bae, S. B. Kwon, K. Lee, D. Young, J. H. Lee, J. S. Song, and S. H. Lee. 2005. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23-lactamase in Korea. J. Clin. Microbiol. 43, 2241-2245.
16. Koeleman, J. G., J. Stoof, M. W. van Der Bijl, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2001. Identification of epidemic strains of Acinetobacter baumannii by Integrase Gene PCR. J. Clin. Microbiol. 39, 8-13.
17. Lévesque, C., L. Piché, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39, 185-191.
18. Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistancenodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45, 3375-3380.
19. Maiden, M. C., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95, 3140-3145.
20. Marchand, I., L. Damier-Piolle, P. Courvalin, and T. Lambert. 2004. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 48, 3298-3304.
21. Poirel, L., A. Karim, A. Mermat, I. Le Thomas, H. Vahaboglu, C. Richard, and P. Nordmann. 1999. Extended-spectrum betalactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J. Antimicrob. Chemother. 43, l57-165.
22. Poirel, L. and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836.
23. Pournaras, S., A. Markogiannakis, A. Ikonomidis, L. Kondyli, K. Bethimouti, A. N. Maniatis, N. J. Legakis, and A. Tsakris. 2006. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J. Antimicrob. Chemother. 57, 557-561.
24. Riccio, M. L., N. Franceschini, L. Boschi, B. Caravelli, G. Cornaglia, R. Fontana, G. Amicosante, and G. M. Rossolini. 2000. Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 44, 1229-1235.
25. Sergio, G. B., H. Seifert, C. Hippler, M. A. Luzon, H. Wisplinghoff, and F. Rodríguez-Valera. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43, 4382-4390.
26. Shi, W. F., J. P. Jiang, N. Xu, Z. M. Huang, and Y. Y. Wang. 2005. Inhibitory effects of reserpine and carbonyl cyanidem-chlorophenylhydrazone on fluoroquinolone resistance of Acinetobacter baumannii. Clin. Med. J. (Engl). 118, 340-343.
27. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233-2239.
28. Tian, S. F., B. Y. Chen, Y. Z. Chu, and S. Wang. 2008. Prevalence of rectal carriage of extended-spectrum -lactamase-producing Escherichia coli among elderly people in community settings in China. Can. J. Microbiol. 54, 781-785.
29. Vahaboglu, H., F. Budak, M. Kasap, G. Gacar, S. Torol, A. Karadenizli, F. Kolayli, and C. Eroglu. 2006. High prevalence of OXA-51-type class D-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centers. J. Antimicrob. Chemother. 58, 537-542.
30. Van, L. M., H. Goossens, and ARPAC Steering Group. 2004. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect. 10, 684-704.
31. Wang, H., M. Chen, Y. Ni, Y. Liu, H. Sun, Y. Yu, X. Yu, Y. Mei, M. Liu, Z. Sun, Y. Chu, Z. Hu, and X. Huang. 2005. Antimicrobial resistance analysis among nosocomial Gram-negative bacilli from 10 teaching hospitals in China. Chin. J. Lab. Med. 28, 1295-1303.
32. Wang, H., P. Guo, H. Sun, H. Wang, Q. Yang, M. Chen, Y. Xu, and Y. Zhu. 2007. Molecular epidemiology of clinical isolates of carbapenemresistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51, 4022-4028.
33. Yoo, J. H., J. H. Choi, W. S. Shin, D. H. Huh, Y. K. Cho, K. M. Kim, M. Y. Kim, and M. W. Kang. 1999. Application of infrequentrestriction-site PCR to clinical isolates of Acinetobacter baumannii and Serratia marcescens. J. Clin. Microbiol. 37, 3108-3112.